Enveric Biosciences
ENVB
8 hedge funds and large institutions have $233K invested in Enveric Biosciences in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0.14% more ownership
Funds ownership: 0.79% → 0.93% (+0.14%)
18% less capital invested
Capital invested by funds: $283K → $233K (-$50.6K)
20% less funds holding
Funds holding: 10 → 8 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$109K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$85.2K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$24.8K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$380 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$44.8K |
| 2 |
VF
Virtu Financial
New York
|
-$25K |
| 3 |
Morgan Stanley
New York
|
-$15.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$577 |
| 5 |
Jones Financial Companies
Des Peres,
Missouri
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AI
1
AdvisorShares Investments
Bethesda,
Maryland
| $130K | +$109K | +8,333 | +96% |
|
|
2
UBS Group
Zurich,
Switzerland
| $67.3K | +$85.2K | +6,500 | +285% |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $18.2K | +$380 | +29 | +1% |
|
|
4
Citadel Advisors
Miami,
Florida
| $14.5K | +$24.8K | +1,890 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $1.55K | -$577 | -44 | -18% |
|
6
BlackRock
New York
| $384 | – | – | – |
|
|
SS
7
SBI Securities
Tokyo,
Japan
| $384 | – | – | – |
|
8
Bank of America
Charlotte,
North Carolina
| $17 | – | – | – |
|
9
National Bank of Canada
Montreal,
Quebec, Canada
| $3 | – | – | – |
|
10
Group One Trading
Chicago,
Illinois
| $1 | – | – | – |
|
11
Wells Fargo
San Francisco,
California
| $1 | – | – | – |
|
|
12
Renaissance Technologies
New York
| – | -$44.8K | -3,084 | Closed |
|
|
VF
13
Virtu Financial
New York
| – | -$25K | -1,730 | Closed |
|
|
14
Morgan Stanley
New York
| – | -$15.8K | -1,085 | Closed |
|
|
15
Jones Financial Companies
Des Peres,
Missouri
| – | -$1 | – | – |
|
ENVB Hedge Fund Activity: Q3 2025 in Review
8 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Enveric Biosciences (ENVB) for Q3 2025, worth a combined $233K — down 18% from $283K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ENVB and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was AdvisorShares Investments, adding an estimated $109K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $44.8K sold.
- 8 institutional investors held Enveric Biosciences (ENVB) as of Q3 2025, down from 10 in Q2 2025.
- Funds reported $233K of Enveric Biosciences stock for Q3 2025, down 18% quarter-over-quarter.
- 1 fund opened new Enveric Biosciences positions in Q3 2025 and 3 closed out, a net change of -2 holders.
- The largest Enveric Biosciences buyer in Q3 2025 was AdvisorShares Investments, an estimated $109K added.
- The largest Enveric Biosciences seller in Q3 2025 was Renaissance Technologies, an estimated $44.8K sold.
Based on aggregated 13F filings for Q3 2025.